Not financial advice · For informational purposes only
Not financial advice · For informational purposes only
REGENXBIO Inc. (RGNX) trades at $9.43, +3.34% on the day (open $9.01, high $9.46, low $8.94, volume 0.41M shares). The company operates in the biological products, (no diagnostic substances) sector. Current market cap is $470.75M.
ArbibX runs Claude AI across a curated universe of liquid US stocks every hour, surfacing the 15 most actionable picks with confidence scores, target prices, and risk notes. The terminal also includes a sector heatmap, watchlists with price alerts, portfolio tracking with AI grading, and a built-in conversational AI that answers questions about any ticker using live market data.
What is the current price of RGNX?
RGNX (REGENXBIO Inc.) is currently trading at $9.43, up 3.34% on the day. Pricing updates in real time on ArbibX during market hours.
Where can I find AI analysis for RGNX?
ArbibX runs Claude AI across a wide universe of US stocks and surfaces the most actionable picks in the AI Top 15 tab. For a question-and-answer style analysis on RGNX specifically, use the in-app "Ask Claude" assistant — it sees the live price, sector, and your portfolio context, and replies with reasoning grounded in today's numbers.
Is RGNX a buy?
Whether RGNX is a buy depends on your investment goals, time horizon, and risk tolerance. Use ArbibX's AI analysis, the 90-day chart, technical indicators, news feed, and the earnings calendar to make an informed decision. Always do your own research and consider consulting a licensed advisor before investing.
Not financial advice · For informational purposes only · Data via Polygon.io